Pacira BioSciences' Current Assets fell 1843.82% to $562.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $562.8 million, marking a year-over-year decrease of 1843.82%. This contributed to the annual value of $745.1 million for FY2024, which is 4610.56% up from last year.
As of Q3 2025, Pacira BioSciences' Current Assets stood at $562.8 million, which was down 1843.82% from $745.6 million recorded in Q2 2025.
In the past 5 years, Pacira BioSciences' Current Assets registered a high of $866.0 million during Q4 2021, and its lowest value of $376.1 million during Q1 2023.
For the 5-year period, Pacira BioSciences' Current Assets averaged around $624.6 million, with its median value being $632.2 million (2024).
Per our database at Business Quant, Pacira BioSciences' Current Assets soared by 7387.87% in 2021 and then tumbled by 4361.26% in 2023.
Quarter analysis of 5 years shows Pacira BioSciences' Current Assets stood at $866.0 million in 2021, then tumbled by 42.46% to $498.3 million in 2022, then rose by 2.34% to $510.0 million in 2023, then skyrocketed by 46.11% to $745.1 million in 2024, then fell by 24.48% to $562.8 million in 2025.
Its last three reported values are $562.8 million in Q3 2025, $745.6 million for Q2 2025, and $760.0 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value